Rising Trends in Nicotine, Cannabis, Vaping, and Psychedelics Use in the United States

New research highlights a surge in nicotine pouches, cannabis, vaping, and psychedelics among U.S. adults and youth, reflecting changing drug use patterns and public health challenges.
Recent data from the University of Michigan's Monitoring the Future Panel reveals a notable increase in the use of various substances among U.S. adults and young people. The report highlights a significant rise in nicotine pouch usage, with a doubling from 2023 to 2024, reaching 9.5% among those aged 19 to 30. Cannabis consumption remains high, with usage rates at or near historic peaks across multiple age groups, especially among adults aged 19 to 30 and 35 to 50. Vaping of cannabis and nicotine has also surged, hitting record levels in 2024—doubled since 2017 for cannabis and tripled for nicotine among young adults. Additionally, the prevalence of psychedelic drug use has continued its upward trajectory, reaching highest levels ever recorded, particularly among adults aged 19 to 50. The longitudinal surveys emphasize how these behaviors evolve over time, providing valuable insights into the impacts of substance use across different stages of adulthood. Megan Patrick, a research professor involved in the study, underscores the importance of tracking these patterns to inform public health responses and understand long-term health effects. The findings also note that alcohol remains the most commonly used substance, with shifting patterns indicating increased acceptance and experimentation with cannabis, vaping, and hallucinogens, prompting ongoing concern and research efforts. The full report offers comprehensive analysis on substance use trends, including data on college-attending young adults and non-college peers, underscoring the dynamic landscape of drug use in contemporary America.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Disparities in Heart Attack Care Highlight Need for Policy Action
New research reveals racial and ethnic disparities in the treatment of heart attack patients, emphasizing the need for systemic improvements to ensure equitable care for all.
Artificial Intelligence Develops Two Novel Antibiotics Against Drug-Resistant Superbugs
MIT researchers have used AI to design two new antibiotics targeting resistant superbugs, marking a promising advancement in overcoming antimicrobial resistance. While further testing is needed, this innovative approach could transform future infectious disease treatments.
Rising Breast Cancer Cases Among Young Women Highlighted by Celebrity Stories
Increasing breast cancer diagnoses among young women in the U.S. are highlighted by celebrity stories, emphasizing the need for awareness, early detection, and risk factor management.
Innovative Triple-Checkpoint Therapy Shows Promise for Resistant Melanoma
New triple-checkpoint immunotherapy demonstrates promising results in treating resistant melanoma, restoring immune response and reducing tumors without added toxicity. Source: sciencex.com